Neurofibromatosis: analysis of clinical cases and new diagnostic criteria
| Autor: | E. S. Makashova, K. O. Karandasheva, S. V. Zolotova, M. A. Ginzberg, M. Yu. Dorofeeva, M. V. Galkin, A. V. Golanov |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Нервно-мышечные болезни, Vol 12, Iss 1, Pp 39-48 (2022) |
| Druh dokumentu: | article |
| ISSN: | 2222-8721 2413-0443 |
| DOI: | 10.17650/2222-8721-2022-12-1-39-48 |
| Popis: | Neurofibromatoses are a group of genetic disorders with predisposing for central and peripheral nervous system tumor development. The group includes three entities: neurofibromatosis type I, neurofibromatosis type II and schwannomatosis, which are characterized by gradual phenotype development and have a partially overlapping spectrum of manifestations, which complicates diagnosis establishing, especially at the stage of clinical onset. At the same time, the emergence of new pathogenetic therapy and the high risk of transmission to descendants actualize the necessity of early diagnosis. DNA tests allow us to reliably confirm the presumed diagnosis. This article presents a review of neurofibromatoses, their clinical features and courses, modern diagnostic criteria and indications for DNA tests. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|